Status:
COMPLETED
Long Term Predictors of Acute Myocardial Infarction in Patients With Coronary Revascularization
Lead Sponsor:
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Conditions:
Acute Myocardial Infarction
Revascularization
Eligibility:
All Genders
Brief Summary
Worldwide, Ischemic heart disease is the single most common fatal disease. One of the most common causes of acute myocardial infarction is represented by obesity. Numerous cardio metabolic variables p...
Eligibility Criteria
Inclusion
- Patients met the criteria for Acute Coronary Syndrome (ACS) as defined by the Joint European Society of Cardiology/American College of Cardiology Committee.
- Patients underwent immediate coronary revascularization (primary PCI) for ST-Elevation Myocardial Infarction (STEMI).
- Patients underwent coronary revascularization (early PCI) within 24 hours for Non-ST-Elevation Myocardial Infarction (NSTEMI).
- Patients underwent diagnostic coronary angiography following coronary artery bypass graft surgery (CABG).
Exclusion
- Known coronary artery disease or previous ACS.
- PCI following CABG.
- Cardiogenic shock.
- Atrial fibrillation.
- Peripheral artery disease.
- Severe cardiac valve disease.
- Prosthetic aorta.
Key Trial Info
Start Date :
January 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
652 Patients enrolled
Trial Details
Trial ID
NCT06546228
Start Date
January 13 2021
End Date
December 31 2022
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria G. Martino
Messina, Italy